baber/WOPTO huggingface dataset:
Patent CA-2735905-A1 (CA)
Title: Element de protection pour calecon de cycliste
Inventor: LAMBERTZ BODO W
IPC: A41D1/084
Filed: 2009-09-03
Abstract: L'invention concerne un élément de protection pour caleçon de cycliste qui présente une zone de protection avant (1) et une zone de protection arrière (2) qui sont reliées ensemble par un rétrécissement (3). Les zones de protection (1, 2) et le rétrécissement (3) ont respectivement une surface (10) qui présente une structure tridimensionnelle.
Patent CA-2736079-A1 (CA)
Title: Hybrid terrain-adaptive lower-extremity systems
Inventor: HERR HUGH MILLER
IPC: H02K41/02
Filed: 2009-09-01
Abstract: Hybrid terrain-adaptive lower-extremity apparatus and methods that perform in a variety of different situations by detecting the terrain that is being traversed, and adapting to the detected terrain. In some embodiments, the ability to control the apparatus for each of these situations builds upon five basic capabilities:  (1) determining the activity being performed; (2) dynamically controlling the characteristics of the apparatus based on the activity that is being performed; (3) dynamically driving the apparatus based on the activity that is being performed; (4) determining terrain texture irregularities (e.g., how sticky is the terrain, how slippery is the terrain, is the terrain coarse or smooth, does the terrain have any obstructions, such as rocks) and (5) a mechanical design of the apparatus that can respond to the dynamic control and dynamic drive.
Patent CA-2737340-A1 (CA)
Inventor: MARAGNI PAOLO
IPC: C07D311/58
Filed: 2009-10-28
Abstract: The present invention relates to a process for preparing Nebivolol and, more particularly, to an improved method of debenzylation of a compound of formula (II) useful for preparing nebivolol endowed with high purity.
Patent CA-2737667-A1 (CA)
Inventor: BABCOOK JOHN
IPC: C07K16/28
Filed: 2009-09-18
Abstract: The invention relates to targeted binding agents against CD105 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to CD105. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of CD105 and as diagnostics.
Patent CA-2741010-A1 (CA)
Inventor: BLOKKER PETER
IPC: G01K7/00
Filed: 2009-10-29
Abstract: This invention provides a method for detecting contamination of a boiler condensate and/or a boiler feedwater in industrial fermentation processes. The method includes measuring an oxidation-reduction potential at one or more locations in the fermentation process with one or more devices capable of measuring oxidation-reduction potential at operating temperature and pressure. If the measured oxidation-reduction potential is not within an optimum range, an alarm is triggered.
Patent CA-2741986-A1 (CA)
Inventor: DIN BELLE DAVID
IPC: A61P25/00
Filed: 2009-11-20
Abstract: Compounds of formula (I), wherein X, Z, A, B, D, E, R1-R4 and m are as defined in the claims, exhibit alpha2C antagonistic activity and are thus useful as alpha2C antagonists.
Patent CA-2742920-A1 (CA)
Inventor: PREHM PETER
IPC: A61K31/16
Filed: 2009-12-14
Abstract: The present invention relates in general to a compound which is characterized by a formula selected from the following formulas A, B, C, D, E or F;     (see formula A) (see formula B) (see formula C) (see formula D) (see formula E) (see formula F) or a pharmaceutically acceptable salt thereof. The present invention further relates to pharmaceutical composition comprising the inhibitor(s) of the invention and to their use in the treatment of (for treating) a disease which is associated with an excess transport of hyaluronan across a lipid bilayer. The present invention furthermore relates to the use of at least one inhibitor of the invention for the preparation of a pharmaceutical composition for the treatment of (for treating) a disease which is associated with an excess transport of hyaluronan across a lipid bilayer. The present invention also relates to a method for manufacturing a pharmaceutical composition comprising the steps of formulating the inhibitor defined herein in a pharmaceutically acceptable form.
Patent CA-2744866-A1 (CA)
Inventor: BOYD MALCOLM
IPC: A61M5/315
Filed: 2009-12-01
Abstract: A medication delivery device (1) comprises a housing (4) having a proximal end (P) and a distal end (D), a cartridge (3) for holding a medication (M), the cartridge (3) having an outlet (2), a moveable piston (5) being retained within the cartridge (3), a drive member (17) moveable in a proximal direction with respect to the housing (4) for setting a dose of medication (M) to be delivered and in the distal direction with respect to the housing (4) for delivering the dose and a piston rod (10) adapted to drive the piston (5) in a distal direction with respect to the cartridge (3) for delivering the dose. The drive member (17) is releasably coupled to the piston rod (10). The medication delivery device (1) further comprises a resilient member (21 ) which is arranged to move the drive member (17) in the proximal direction with respect to the housing (4) after dose delivery, thereby reducing pressure of the piston rod (10) on the piston (5).
Patent CA-2744875-A1 (CA)
Inventor: IMAJUKU WATARU
IPC: H04B1/74
Filed: 2004-02-20
Abstract: In a disclosed backup path bandwidth reservation method for reserving bandwidth of a backup path to which an active path is switched when the active path becomes unavailable in nodes of a communication network, the method includes a backup path bandwidth reservation phase, for reserving M(M is a natural number equal to or less than L) channels of L (L is a natural number) channels reserved as backup path bandwidth, by notifying a destination-side node existing in a destination side of the backup path of identification number information of the M channels to be reserved and identification information indicating that a path for which the bandwidth is to be reserved is a backup path.
Patent CA-2745519-A1 (CA)
Inventor: WALLACE NIALL
IPC: G06F17/40
Filed: 2009-12-08
Abstract: The present invention is a system and method for disease mapping and infection control. It may collect data from many sources, including through the tracking of Entities and external sources.  Such data may be analysed by the system and represented visually. The system further facilitates data modelling. The present invention facilitates calculations of risk and exposure to an infection posed to a person, location or community. The system may be used to test and monitor infection spread and control measures. It can further be configured so as to produce reporting based upon its data to produce information relevant to the creation of infection control policies. The reports may also be utilized to develop standards and measures to improve the operation response to an outbreak of infection within an Institution or a Geographical Area, at the syndromic or pandemic levels.
Patent CA-2747493-A1 (CA)
Inventor: RUAN CHIA-WEN
IPC: H02J7/00
Filed: 2011-07-27
Abstract: A power supplying system includes multiple rechargeable battery devices each including a first switch module, a series connection of a battery unit which includes multiple rechargeable batteries connected in series with each other and a second switch module connected in parallel to the first switch module, and a control module for controlling operations of the first and second switch modules. For each rechargeable battery device, the first and second switch modules are normally operated in an OFF-state and an ON-state, respectively, and the control module enables the first and second switch modules to switch respectively from the OFF-state and the ON-state to an ON-state and an OFF-state upon detecting that a voltage of any one of the rechargeable batteries of the battery unit is not within a predetermined voltage range during charging or discharging of the battery unit.
Patent CA-2751117-A1 (CA)
Title: Equipage mobile et transducteur electrodynamique pourvu d'un tel equipage mobile
Inventor: LEMARQUAND GUY
IPC: H04R9/04
Filed: 2010-01-27
Abstract: La présente invention concerne un équipage mobile (1) pour transducteur électrodynamique,, comprenant au moins un mandrin (2) support d'enroulement d'au moins un fil (3) bobiné, caractérisé par le fait que ledit mandrin (2) comprend au moins un premier élément (4) solidaire intérieurement d'au moins un second élément (5) de guidage de l'équipage mobile (1) au sein dudit transducteur, ledit premier élément (4) constituant, d'une part, un support d'enroulement dudit fil bobiné (3) de sorte que le bobinage se situe à l'intérieur dudit mandrin (2) et, d'autre part, des moyens d'émission de vibrations, tel un diaphragme, lesdites vibrations étant générées par le déplacement du bobinage induit par le passage du courant à l'intérieur du fil bobiné (3). L'invention concerne aussi un transducteur électrodynamique équipé d'un tel équipage mobile (1).
Patent CA-2753842-A1 (CA)
Title: Substrat muni d'un empilement a proprietes thermiques comportant des couches a haut indice de refraction
Inventor: GERARDIN HADIA
IPC: C03C17/36
Filed: 2010-03-08
Abstract: L'invention se rapporte à un substrat (10) verrier muni sur une face principale d'un empilement de couches minces comportant une couche fonctionnelle (40) métallique à propriétés de réflexion dans l'infrarouge et/ou dans le rayonnement solaire, notamment à     base d'argent ou d'alliage métallique contenant de l'argent, et deux revêtements antireflet (20, 60), lesdits revêtements comportant chacun au moins deux couches diélectriques (22, 24, 26,- 62, 64, 66), ladite couche fonctionnelle (40) étant disposée entre les deux revêtements antireflet (20, 60), caractérisé en ce que chaque revêtement antireflet (20, 60) comporte au moins une couche diélectrique à haut indice de réfraction (24, 64) située au contact ou a proximité de la couche fonctionnelle (40), c'est-à-dire à 10 nm ou moins de la couche fonctionnelle (40).
Patent CA-2754592-A1 (CA)
Inventor: HENRY WILLIAM
IPC: A61P37/02
Filed: 2010-03-09
Abstract: This invention relates to immunogenic compositions for inducing an immune response against an antigen of interest.  In particular, the invention provides immunogenic compositions comprising an antigen-carrier conjugate, wherein the carrier is a bacterial toxin that contains a signal peptide. The invention also provides methods of generating immunogenic compositions with enhanced immunogenic ity, comprising adding a signal peptide to the bacterial carrier in an antigen-carrier conjugate, such as a hapten-carrier conjugate. The invention also provides methods for inducing an immune response to a hapten in a subject using these immunogenic compositions.
Patent CA-2757134-A1 (CA)
Title: Improvements in and relating to medicament delivery devices
Inventor: LANGLEY CHRISTOPHER NIGEL
IPC: A61M5/315
Filed: 2010-03-24
Abstract: A medicament delivery device (1) comprises a housing (2) for holding a medicament cartridge (9), a piston rod (22, 24) and a drive (11, 20). The medicament cartridge (9) has a medicament outlet and a bung (13) moveable axially along the medicament cartridge for dispensing a medicament, the piston rod has a plunger (24) for moving the bung and a lead member (22) telescopically coupled to the plunger (24) that may be driven by the drive (11, 20) to extend or retract the piston rod (22, 24). Additionally, the device comprises a linkage (40) coupled between the plunger (24) and an anchorage (44) and a drive member (20) telescopically coupled to the lead member (22). The drive (11) is operative to rotate the drive member (20) to telescopically move the lead member relative to the drive member whereby the plunger is moved relative to the lead member by way of the linkage (40).
Patent CA-2759176-A1 (CA)
Title: Compositions pharmaceutiques comprenant de l'epa et un agent cardiovasculaire et methodes pour les utiliser
Inventor: MANKU MEHAR
IPC: A61P3/04
Filed: 2010-04-29
Abstract: La présente invention porte, entre autres, sur des compositions pharmaceutiques comprenant de l'EPA et un ou plusieurs agents cardiovasculaires, et sur des procédés thérapeutiques de traitement de diverses maladies et divers troubles les utilisant.
Patent CA-2759751-A1 (CA)
Inventor: HENDRICKS JOHN S
IPC: H04N7/24
Filed: 2002-10-10
Abstract: A method and an apparatus are used to target interactive virtual objects to subscribers in a television delivery system. Programs are selected and virtual object locations are defined in the selected programs. The virtual objects (1265) available for targeting categorized and categories are correlated to subscriber information (1210) to determine the optimum targeting of the virtual objects (1260). The virtual objects may be targeted (1220) based on individual subscriber information (1210) or an on information related to a group of subscribers. When a frame of program includes a virtual object location, a default or an alternate virtual object is displayed. The virtual object location may change over space or time. The virtual object may be interactive, and may be used to link a subscriber to a remote location, such as an Internet web site.
Patent CA-2759894-A1 (CA)
Title: Safety element for a diesel fuel container to prevent adding the wrong fuel
Inventor: TSIBERIDIS KONSTANTINOS
IPC: B60K15/04
Filed: 2010-02-23
Abstract: The invention relates to an insert element (13) for a diesel fuel container, which can be installed in the filling opening (10) of the container, in particular in a filler neck, for the purpose of filling with diesel fuel using a pump nozzle at the gas station, wherein the insert element (13) comprises an elongated, substantially tubular holding element (16), which can be fitted into the container opening and comprises an inlet side and an outlet side and in which a molded part (18) is held, which is elongated in parallel to the holding element (16) and the free face of which projecting toward the inlet side has an outside diameter that is smaller than the inside diameter of an outlet tube (12) of a diesel pump nozzle, however that is larger than the inside diameter of an outlet tube of a gas pump nozzle. Further, an actuating element is provided, which can be displaced coaxially to the filling opening on the inside wall of the holding element (16) and is arranged so as to remain behind the face of the molded part (18) in the direction of the container interior, wherein said actuating element is able to actuate a closing cap arranged on the outlet side of the holding element (16) when displaced in the direction toward the interior of the container.
Patent CA-2761971-A1 (CA)
Title: Rice bran extracts for inflammation and methods of use thereof
Inventor: ALBERTE RANDALL S
IPC: A23L7/10
Filed: 2009-05-18
Abstract: The present invention relates in part to stabilized rice bran extracts enriched in compounds that have inhibitory activity against certain anti- inflammatory therapeutic endpoints, such as the COX-1, COX-2 and 5-LOX enzymes. Another aspect of the invention relates to pharmaceutical compositions comprising the extracts and to methods of treating inflammatory diseases comprising administering the aforementioned extracts.
Patent CA-2762181-A1 (CA)
Inventor: MIZRAHI LIRON SHMUEL
IPC: A61B6/00
Filed: 2011-12-15
Abstract: An apparatus, including a transparent panel, which is configured to protect an operator positioned on a first side of the panel from X-ray radiation applied to a patient on a second side of the panel during a medical procedure, while permitting the operator to view the patient through the panel. The apparatus also includes a display device, which is coupled to present information on the transparent panel responsively to the medical procedure.
Patent CA-2767172-A1 (CA)
Title: Compositions containing benefit agent delivery particles
Inventor: MEEK MICHELLE
IPC: C11D3/22
Filed: 2010-07-08
Abstract: The present disclosure relates to compositions containing benefit agent delivery particles containing at least one benefit agent and at least one cellulosic polymer. The disclosure further relates to compositions containing benefit agent delivery particles and processes for making and using such compositions. The disclosure further relates to methods of imparting a benefit delivery capability to a cleaning composition.
Patent CA-2767922-A1 (CA)
Title: Cocoalkylpolyamine alkoxylates as agents for high strength herbicide compositions
Inventor: PARR RODNEY WALTER
IPC: A01N25/30
Filed: 2010-07-22
Abstract: Embodiments of the present invention disclose an agricultural composition having an agrochemical active ingredient and at least one cocoalkylpolyamine alkoxylate agent.
Patent CA-2770885-A1 (CA)
Inventor: WHITEHOUSE ROBERT S
IPC: C08G63/06
Filed: 2010-08-27
Abstract: Toughened polyhydroxyalkanoate resin compositions are disclosed, comprising thermoplastic polyhydroxyalkanoate compositions and a toughener comprising a vinyl acetate homopolymer or copolymer and optionally polyvinyl alcohol.
Patent CA-2772143-A1 (CA)
Inventor: KURNIK RONALD T
IPC: G16B40/10
Filed: 2010-08-25
Abstract: Systems and methods for processing PCR curves and for identifying the presence of a parabolic-shaped PCR curve are provided. The use of a piecewise linear approximation of a PCR curve enables a more realistic elbow value to be determined in the case of parabolic shaped PCR curves.
Patent CA-2774460-A1 (CA)
Inventor: SULLENGER BRUCE A
IPC: A61K38/16
Filed: 2010-09-16
Abstract: The present invention relates, in general, to pattern-recognition receptors (PRRs), including toll-like receptors (TLRs), and, in particular, to a method of inhibiting nucleic acid-induced activation of, for example, endosomal TLRs using an agent that binds to the nucleic acid ("nucleic acid binding agent"), preferably, in a manner that is independent of the nucleotide sequence, the chemistry (e.g., DNA or RNA, with or without base or sugar modifications) and/or the structure (e.g., double-stranded or single-stranded, complexed or uncomplexed with, for example protein) of the nucleic acid(s) responsible for inducing TLR activation. The invention also relates to methods of identifying nucleic acid binding agents suitable for use in such methods.
Patent CA-2775441-A1 (CA)
Inventor: KLITSCHKE JAN
IPC: C08G69/20
Filed: 2012-05-02
Abstract: A composition comprising a) at least one aliphatic or cycloaliphatic isocyanate compound having at least two isocyanate groups and b) at least one lactone, containing 4 to 7 carbon atoms and use of the composition as an activator for anionic lactam polymerization to obtain polyamides.
Patent CA-2777719-A1 (CA)
Inventor: ZELDIS JEROME B
IPC: A61P43/00
Filed: 2010-11-18
Abstract: Provided herein are methods of treating, preventing and/or managing sarcoidosis by the administration of (+)-2-[ 1 -(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-4- acetylaminoisoindolin-l,3-dione, alone or in combination with other therapeutics.
Patent CA-2778274-A1 (CA)
Title: Endometrial ablation devices and system
Inventor: TRUCKAI CSABA
IPC: A61B18/04
Filed: 2010-10-26
Abstract: Systems and methods for endometrial ablation. The systems include a handle and elongated introducer sleeve extending to an expandable working end having a fluid-tight interior chamber. A thin dielectric wall surrounds at least a portion of the interior chamber and has an external surface for contacting endometrial tissue. The thin dielectric wall surrounds a collapsible-expandable frame and receives an electrically non-conductive gas. First and second polarity electrodes are exposed to the interior and exterior of the chamber, respectively. A radiofrequency power source operatively connects to the electrode arrangement to apply a radiofrequency voltage across the first and second electrodes, wherein the voltage is sufficient to initiate ionization of the neutral gas into a conductive plasma within the interior chamber, and to capacitively couple the current in the plasma across the thin dielectric wall to ablate endometrial tissue engaged by the external surface of the dielectric structure.
Patent CA-2779121-A1 (CA)
Title: Recompaction of sand reservoirs
Inventor: YALE DAVID P
IPC: E21B43/12
Filed: 2012-06-07
Abstract: Methods and systems for recompacting a hydrocarbon reservoir to prevent override of a fill material are provided. An exemplary method includes detecting a slurry override condition and reducing a pressure within the reservoir so as to reapply a stress from an overburden.
Patent CA-2781476-A1 (CA)
Inventor: SWADDLE GARY
IPC: A61M5/158
Filed: 2012-06-26
Abstract: An infusion catheter system comprises a surgical needle and an infusion catheter. The infusion catheter has an internal bore; and the needle has a protrusion extending from its proximal end. The protrusion is adapted to mate with the internal bore of the infusion catheter. Through this innovative connection method, the needle can take the same diameter as the catheter. Therefore the puncture marks caused in the patient will have a smaller diameter than with conventional "introducer needles", reducing pain, leakage and the chances of infection. Furthermore, the catheter may be introduced subcutaneously, further reducing the risk of infection by eliminating the risk of skin bacteria being drawn into the wound cavity.
Patent CA-2786027-A1 (CA)
Inventor: OGAWA TOMOHIRO
IPC: H01M8/04
Filed: 2011-12-12
Abstract: The procedure of the invention successively obtains an estimated value of amount of liquid water in a fuel cell during operation in each specified period by the following steps (a) to (d), thereby improving the detection accuracy of the water condition inside the fuel cell. The step (a) obtains a previous estimated value. The step (b) obtains a drainage rate that represents an amount of liquid water discharged from the fuel cell per unit time, based on the previous estimated value and a value representing a current flow rate of a reactive gas in the fuel cell. The step (c) multiplies the drainage rate by a period of obtaining the estimated value, so as to calculate an amount of liquid water discharged from the fuel cell for a specified duration. The step (d) determines a current estimated value, based on the amount of liquid water discharged from the fuel cell for the specified duration.
Patent CA-2786155-A1 (CA)
Inventor: PUGLIESE MARCO
IPC: A61P25/00
Filed: 2011-01-04
Abstract: The invention relates to the use of diazoxide or a pharmaceutically acceptable salt thereof at low doses to treat a CNS autoimmune demyelinating disease selected from selected from multiple sclerosis (MS), clinically isolated syndrome (CIS), tumefactive (tumor-like) MS, Marburg's acute MS, Bal?s's concentric sclerosis, acute disseminated encephalomyelitis (ADEM), post-vaccinal encephalitis (PVE), post-infectious encephalomyelitis (PIE) and neuromyelitis optica (NMO).
Patent CA-2786552-A1 (CA)
Inventor: MCALPINE JAMES EDWARD
IPC: E03C1/298
Filed: 2010-11-23
Abstract: A non-return device (10) for use with a waste trap is described. The non-return device comprises a sealing portion (12) having first and second sheet members (14, 16), a device inlet (18), a device outlet (20) and a transition portion (22) providing fluid communication between the device inlet and the sealing portion. The transition portion has a convex section of wall (24).
Patent CA-2788209-A1 (CA)
Title: Method and material for paving a surface
Inventor: CAMPBELL BARTH
IPC: C04B24/00
Filed: 2012-08-30
Abstract: A method and material for paving a surface, such as a dirt trail, is disclosed. The method includes obtaining raw chert material which is composed primarily of particles of gravel, sand, and clay obtained from a quary or mine, and which has been screened to remove particles of a size of one inch or more. The screened chert is mixed to achieve consistency of the material, then mixed with a predetermined quantity of an aqueous enzyme solution. The aqueous enzyme solution contains an enzyme fluid mixesd with water in the ratio of .02 to 5 gallons of enzyme fluid to 400 to1000 gallons of water. The material-solution mix is than applied to a surface in layers and compacted to achieve a finished thickness of about 6 to 10 inches. After a delay of 48 hours, the paved surface is usable by equipment and vehicles.